Abstract
AbobotulinumtoxinA (Dysport®) shows efficacy in a model of MRMT-1–induced bone cancer pain in the rat
Full Text
Sign-in/Register to access full text options
Published version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have